Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
Cancer Research, 07/17/2012
Clinical Article
Le DT et al. – Cyclophosphamide has emerged as a clinically feasible agent that can suppress Tregs and allow more effective induction of antitumor immune responses.



